News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,601 Results
Type
Article (39682)
Company Profile (247)
Press Release (658672)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204160)
Career Advice (2007)
Deals (35416)
Drug Delivery (95)
Drug Development (81043)
Employer Resources (172)
FDA (16180)
Job Trends (14856)
News (345174)
Policy (32535)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (84)
Alliances (49426)
ALS (88)
Alzheimer's disease (1376)
Antibody-drug conjugate (ADC) (124)
Approvals (16185)
Artificial intelligence (250)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2248)
Cardiovascular disease (173)
Career advice (1675)
Career pathing (30)
CAR-T (150)
Cell therapy (419)
Cervical cancer (19)
Clinical research (65969)
Collaboration (832)
Compensation (524)
Complete response letters (19)
COVID-19 (2588)
CRISPR (39)
C-suite (240)
Cystic fibrosis (100)
Data (2195)
Decentralized trials (2)
Denatured (18)
Depression (42)
Diabetes (269)
Diagnostics (6367)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86567)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112329)
Executive appointments (718)
FDA (17423)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (746)
Gene editing (103)
Generative AI (19)
Gene therapy (299)
GLP-1 (706)
Government (4415)
Grass and pollen (4)
Guidances (59)
Healthcare (18814)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2730)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16507)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (466)
Leadership (16)
Legal (7909)
Liver cancer (75)
Lung cancer (320)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (302)
MASH (66)
Medical device (13373)
Medtech (13378)
Mergers & acquisitions (19451)
Metabolic disorders (680)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1908)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Northern California (2664)
Now hiring (39)
Obesity (361)
Opinion (204)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (231)
Patient recruitment (109)
Peanut (46)
People (57287)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20547)
Phase II (29051)
Phase III (21644)
Pipeline (1184)
Policy (138)
Postmarket research (2563)
Preclinical (8736)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5907)
Recruiting (65)
Regulatory (22269)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (68)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2285)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3575)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (37)
The Weekly (29)
United States (22934)
Vaccines (684)
Venture capitalists (41)
Weight loss (233)
Women's health (35)
Worklife (15)
Date
Today (109)
Last 7 days (847)
Last 30 days (2583)
Last 365 days (32802)
2025 (10498)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (37832)
Australia (6184)
California (6076)
Canada (2004)
China (520)
Colorado (265)
Connecticut (272)
Delaware (146)
Europe (81224)
Florida (904)
Georgia (204)
Idaho (57)
Illinois (528)
India (25)
Indiana (306)
Iowa (11)
Japan (159)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (886)
Massachusetts (4533)
Michigan (217)
Minnesota (388)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1714)
New Mexico (28)
New York (1728)
North Carolina (961)
North Dakota (8)
Northern California (2664)
Ohio (202)
Oklahoma (14)
Oregon (34)
Pennsylvania (1370)
Puerto Rico (12)
Rhode Island (33)
South America (1096)
South Carolina (22)
South Dakota (1)
Southern California (2285)
Tennessee (101)
Texas (899)
Utah (180)
Virginia (143)
Washington D.C. (61)
Washington State (549)
West Virginia (3)
Wisconsin (53)
698,601 Results for "seegene inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Seegene Unveils HPV Genotyping Solution at EUROGIN 2025
March 20, 2025
·
3 min read
Press Releases
Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation
April 9, 2025
·
5 min read
Policy
Seegene obtains ISO45001 certification
Seegene Inc. announced that it has achieved an ISO45001 certification on December 27.
December 27, 2023
·
1 min read
Seegene and UK Health Security Agency convene a summit to collectively realize “a World Free from All Diseases”
Seegene Inc. announced that Prof. Dame Jenny Harries, Chief Executive of the UK Health Security Agency, visited its headquarters located in Seoul Korea, on March 27.
April 8, 2024
·
3 min read
Press Releases
Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative
October 9, 2024
·
4 min read
Seegene Unveils ‘Open Innovation Program Powered by Seegene’ in Partnership with Springer Nature
Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, unveiled its ‘Open Innovation Program powered by Seegene ' in partnership with Springer Nature, a world-leading provider of services to the research community.
September 4, 2023
·
4 min read
Biotech Beach
Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc.Company expands presence and support in US market
Seegene Technologies, Inc. announced it will change names and begin doing business as Seegene USA, Inc. , effective Jan. 1, 2023.
January 6, 2023
·
1 min read
Business
Seegene Announces Collaboration with Microsoft to Realize ‘a World Free from All Diseases’
Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced its selection of Microsoft as a technology partner for its SG OneSystemTM business in London, UK, on January 23 to realize ‘a world free from all diseases.’
January 24, 2024
·
4 min read
Seegene Showcased its Multiplex Technology at ADLM 2024
August 5, 2024
·
3 min read
Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability
Seegene Inc. announced on November 10 that it has received an overall rating of ‘B+' in the 2023 ESG evaluation conducted by the Korea Institute of Corporate Governance and Sustainability.
November 10, 2023
·
2 min read
1 of 69,861
Next
